Strengthening Mozambique's Capacity to Integrate and Sustain High-Quality Laboratory Services and Systems under the President's Emergency Plan for AIDS Relief (PEPFAR)

The summary for the Strengthening Mozambique's Capacity to Integrate and Sustain High-Quality Laboratory Services and Systems under the President's Emergency Plan for AIDS Relief (PEPFAR) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control CGH, which is the U.S. government agency offering this grant.

Strengthening Mozambique's Capacity to Integrate and Sustain High-Quality Laboratory Services and Systems under the President's Emergency Plan for AIDS Relief (PEPFAR): The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $7,000,000 for Year 1, subject to the availability of funds.High-quality laboratory systems and services are essential for accurate diagnosis, treatment, and management of HIV and opportunistic infections (OI) amongst people living with HIV (PLHIV). Mozambique has made tremendous progress toward building technical capacity and optimizing the laboratory network to provide timely access to early infant diagnosis (EID) and viral load (VL) testing services for all eligible clients. VL coverage has rapidly increased from 67% in 2018, to 83% in 2022, contributing to improved patient monitoring and outcomes for PLHIV. This NOFO plans to build upon current accomplishments and support government institutions in Mozambique to strengthen and sustain laboratory systems and services towards achieving the UNAIDS 95-95-95 goals.The NOFO aims to attain comprehensive coverage for both VL and EID testing, facilitate the expansion of HIV testing for enhanced case detection, strengthen the diagnosis of TB and other OI, enhance the governance of laboratory systems, build technical, scientific, and managerial capabilities, and implement robust laboratory data and quality management systems (QMS). This approach encompasses comprehensive quality assurance (QA) and continuous quality improvement (QI) programs essential for HIV rapid test site certification and laboratory accreditation. This NOFO seeks to strengthen integration of laboratory systems and services to support multi-disease testing and improve responsiveness to emerging public health threats.